GlobeNewswire

Align Technology Launches New iTero Element 5D Imaging System for Comprehensive Preventative and Restorative Oral Care at IDS

Del

SAN JOSE, Calif., Feb. 18, 2019 (GLOBE NEWSWIRE) --

  • First intraoral scanner with near-infrared imaging (NIRI) technology that scans the internal structure of a tooth (enamel & dentin) in real time1.
  • First integrated dental imaging system that simultaneously records 3D, intra-oral color and NIRI, and enables comparison over time using iTero® TimeLapse1.
  • NIRI technology of the iTero Element® 5D system aids in detection and monitoring of interproximal caries lesions above the gingiva without using harmful radiation1.
  • New web-based interface MyiTero.com complements visualization of the iTero Element 5D system.
  • Limited-release direct doctor-lab workflow automatically sends scan to lab of choice.

Align Technology, Inc. (NASDAQ: ALGN) today announced that it is launching the iTero Element 5D Imaging System, which provides a new comprehensive approach to clinical applications, workflows and user experience that expands the suite of existing high-precision, full-color imaging and fast scan times of the iTero Element portfolio. The entire iTero product family, including the iTero Element 5D Imaging System, will be showcased at the 38th International Dental Show (IDS) in Cologne Germany, which runs March 12 – 16, 2019.

iTero Element 5D Imaging System: more than just a scanner
In addition to offering all of the features and functionality that doctors have come to expect and rely on with the iTero Element 2 scanner, the iTero Element 5D scanner is the first integrated dental imaging system that simultaneously records 3D, intra-oral color and NIRI images and enables comparison over time using iTero TimeLapse1. Integrated 3D,  intra-oral color and NIRI technology of the iTero Element 5D Imaging System aids in detection and monitoring of interproximal caries lesions above the gingiva without using harmful radiation1. With one full arch scan, in as little as 60 seconds, the iTero Element 5D Imaging System provides doctors with powerful visualization capabilities, including the following:

  • 3D impressions for restorative and orthodontic work
  • Analysis instruments, such as the occlusal clearance tool2
  • NIRI imagery
  • Intraoral camera imagery
  • iTero TimeLapse technology
  • Invisalign® Outcome Simulator2
  • Invisalign Progress Assessment2

“The iTero Element 5D Imaging System combines the cutting-edge technology of the iTero Element portfolio of intraoral scanners, with advanced integrated imaging features, such as NIRI, which aids in interproximal caries detection and clear intra-oral images with the built-in intraoral camera,” said Zelko Relic, Align Technology, CTO and senior vice president, global research and development. “With this new imaging system, doctors can efficiently and effectively scan every patient at every visit and visualize treatment options together that result in more informed decisions for optimum oral care.”  

“Diagnosing carious lesions or ‘cavities,’ especially ones that are interproximal or between teeth, can be hampered by numerous factors, including variations in tooth shape and alignment, traditional X-ray film limitations that include variability in exposure levels, poor angulations in image capture or overlapping contacts in the image, and more,” said Dr. Mitra Derakhshan, Align Technology, vice president, global clinical. “The iTero Element 5D Imaging System aids doctors in detecting and monitoring the progression of interproximal cavities above the gingiva without harmful radiation, thereby helping to ensure that their patients receive even better care.”

Dr. Tim Nolting, a general practioner from Freudenberg, Germany, who was part of the iTero Element 5D Imaging System limited market release said, “The iTero Element 5D scanner has been a real game changer and given me a totally new reason to incorporate digital technology in my practice. Patients value minimally invasive treatment and radiation free diagnosis. With the addition of the iTero Element 5D System in my diagnostic tool box, diagnosis itself is easier to make and since I can show my patients what I am seeing, they understand the situation better and in turn accept the proposed treatment.”

“The pace of innovation at Align continues to accelerate, and the Element 5D Imaging System expands the iTero portfolio by offering dental professionals a wide range of powerful scanning technology at every price point,” said Yuval Shaked, Align Technology, senior vice president and managing director, iTero Scanners and Services.  “As the leader in digital scanning technology with over 20 years of experience, we understand the nature of platform evolution and how important it is to support our doctors and provide an upgrade path that protects their investment. With iTero Element 5D Imaging System, dental professionals now have the ability to invest in more than an intraoral scanner, thus maximizing opportunities within their dental practice. The platform nature of iTero Element 5D System makes it easy for dental professionals to upgrade to the latest digital technology when they are ready.”

MyiTero.com: New web-based interface that frees the scanner for scanning
Align Technology now also offers a web-based platform called MyiTero.com that complements the comprehensive visualization of the iTero Element 5D Imaging System and can be used to set up prescription before the appointment and review scans with the patient on multiple devices, giving the practice the flexibility to assist more patients with this cutting-edge technology. MyiTero.com frees up the scanner so the practice can really maximize the utilization of their scanner and the overall investment in the technology.

Direct doctor-lab workflow in limited release: Workflow options that fit doctor-lab needs
Align Technology is continuing to streamline workflows for dentists and labs with the addition of direct doctor-lab workflow. The new workflow will allow the scan to be automatically sent to the doctor’s lab of choice and the doctor can engage with the lab through the MyiTero.com account to determine if the scan is acceptable or if additional information is needed. This workflow will continue to be supported with on-demand services like iTero modeling and iTero customer milled models, both unique to iTero Element scanners, that the labs have come to count on. Direct doctor-lab workflow is currently in limited market testing in North America and Europe.

1 Data on file at Align Technology, as of December 4, 2018.
2 Comes standard in all iTero Element scanners.

The iTero Element 5D Imaging System is commercially available now in Canada, European Union countries accepting CE-Marking (excluding Greece), Switzerland, Norway, Australia, New Zealand, Hong Kong and Thailand. The iTero Element 5D Imaging System is not yet available in the United States or Latin America.

Information about the iTero Element 5D Imaging System can be found at http://www.itero.com/en.

Align Technology designs and manufactures the Invisalign® system, the most advanced clear aligner system in the world, and iTero® intraoral scanners and services. Align's products help dental professionals achieve the clinical results they expect and deliver effective, cutting-edge dental options to their patients. Visit www.aligntech.com for more information.

For additional information about the Invisalign system or to find an Invisalign doctor in your area, please visit www.invisalign.com. For additional information about the iTero digital scanning system, please visit www.itero.com.

Align Technology                                                                                        
Karina Ludz                                                                                           
(316) 21143420                                                                                      
kludz@aligntech.com                                                                           

Zeno Group
Sarah Johnson
(828) 551-4201
sarah.johnson@zenogroup.com

Photos accompanying this announcement are available at
http://www.globenewswire.com/NewsRoom/AttachmentNg/b06170ee-c19b-4093-b5c1-fcbc8aae9455

http://www.globenewswire.com/NewsRoom/AttachmentNg/76a84de2-12fd-4978-8699-7a7a07d5a706

Om GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg saker fra GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra GlobeNewswire

Abeona Therapeutics Announces FDA Clearance of Investigational New Drug Application for ABO-202 Gene Therapy in CLN1 Disease21.5.2019 14:00:00 CESTPressemelding

NEW YORK and CLEVELAND, May 21, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that the Company is cleared to begin a Phase 1/2 clinical trial evaluating its novel, one-time gene therapy ABO-202 for the treatment of CLN1 disease, following acceptance of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA). ABO-202 is designed to deliver a functional copy of the PPT1 gene to cells of the central nervous system and peripheral organs using a combined intravenous and intrathecal delivery via the AAV9 vector. The Company will provide guidance on the timing of the clinical trial later this year. “This significant step brings hope to people impacted by this devastating disease and was achieved in partnership with Dr. Steven Gray and Taylor’s Tale,” said Timothy J. Miller, Ph.D., Co-Founder, President & Chief Scientific Officer. “We are very encouraged that ABO-202 wa

Invivoscribe Expanding Clinical Laboratory Network Space and Testing Capabilities in San Diego, Germany, Japan, and China. Offering Comprehensive Standardized Testing for All Hematologic Malignancies21.5.2019 12:00:00 CESTPressemelding

SAN DIEGO, May 21, 2019 (GLOBE NEWSWIRE) -- Invivoscribe, Inc., a vertically integrated global company focused on Improving Lives with Precision Diagnostics ®, today announces expansion of space and testing capabilities in their international network of accredited LabPMM® clinical laboratories. Additions to the test menu will include morphology, IHC, flow cytometry, as well as the latest multiparameter flow- (MPF), and NGS-based minimal residual disease (MRD) testing of primary specimens. These new services will further support rapid patient diagnosis, study subject enrollment, and study subject stratifications. They will be available by end of this year in San Diego followed by the laboratories in Japan, Germany and China. “Our comprehensive test menu will eliminate the need for partners to split primary specimens, dramatically decreasing turnaround times and accelerating receipt of comprehensive test reports. This is especially important for partners performing international clinical

Canadian Natural Resources Limited Announces Normal Course Issuer Bid21.5.2019 11:00:00 CESTPressemelding

CALGARY, Alberta, May 21, 2019 (GLOBE NEWSWIRE) -- Canadian Natural Resources Limited ("Canadian Natural") announced today that the Toronto Stock Exchange has accepted notice filed by Canadian Natural of its intention to make a Normal Course Issuer Bid (“NCIB”) through the facilities of the Toronto Stock Exchange or other alternative Canadian trading systems. Purchases may also be made through the facilities of the New York Stock Exchange. The notice provides that Canadian Natural may, during the 12 month period commencing May 23, 2019 and ending May 22, 2020, purchase for cancellation up to 59,729,706 common shares, being 5% of the 1,194,594,136 issued and outstanding common shares as at May 10, 2019. Canadian Natural will not acquire more than 25% of the average daily trading volume of its common shares during a trading day, being 975,709 common shares subject to certain prescribed exceptions. The price which Canadian Natural will pay for any such shares will be the market price at t

Telia Norway signs partner agreement with IMImobile for Enterprise cPaaS offering21.5.2019 09:00:00 CESTPressemelding

Scandinavian telecommunications provider to resell IMImobile’s cPaaS offering, IMIconnect, to enterprise customers LONDON, May 21, 2019 (GLOBE NEWSWIRE) -- IMImobile, a global communications software provider, has signed a partner agreement with Telia Norway, with an option to extend to the wider Telia Company – the leading telecom operator in the Nordic/Baltics. The partner agreement will enable Telia to resell IMImobile’s cloud products, including its enterprise cPaaS (Communications Platform as a Service) offering, IMIconnect, to its enterprise customers. IMIconnect enables businesses to rapidly launch and orchestrate two-way, trigger-based customer communications across 10+ channels. Driven by the changes in person to person communications, consumers now expect interactions with businesses to be personalised, relevant, contextual, interactive and conducted in real time. IMImobile is helping Telia to keep pace with changing consumer expectations and offer innovative communications s

GridGain Joins Cloud Native Computing Foundation21.5.2019 09:00:00 CESTPressemelding

Increasingly Deployed in the Cloud, GridGain Looks to Contribute to Growing Body of Cloud Native Best Practices FOSTER CITY, Calif., May 21, 2019 (GLOBE NEWSWIRE) -- GridGain® Systems, provider of enterprise-grade in-memory computing solutions based on Apache® Ignite™, today announced it has joined the Cloud Native Computing Foundation® (CNCF®) and The Linux Foundation. GridGain is demonstrating its support for the CNCF with a Silver Membership and participating in the foundation’s programs and guidance related to supporting cloud native applications. CNCF is an open source software foundation dedicated to making cloud native computing universal and sustainable. CNCF has over 400 members including the world’s largest public cloud and enterprise software companies as well as dozens of innovative startups. Cloud-native computing uses an open source software stack to deploy applications as microservices, packaging each part into its own container, and dynamically orchestrating those conta

Melissa Showcases All-in-One Identity Verification at Money20/20 Europe21.5.2019 07:00:00 CESTPressemelding

Demos Highlight How to Combat Fraud, Minimise Risk and False Positives, and Maintain Compliance During Frictionless Customer Experience LONDON, May 20, 2019 (GLOBE NEWSWIRE) -- Melissa, a leading provider of global contact data quality and identity verification (IDV) solutions, will demonstrate its all-in-one cloud IDV and enrichment solution at Money20/20 Europe, stand B91. Melissa’s IDV technology operates side-by-side with existing banking and payments software platforms, seamlessly verifying identity using a global dataset of billions of records. In real time and in compliance with the full spectrum of banking regulations and data standards, financial institutions are empowered with trusted banking relationships – combatting fraud and reducing friction in the customer experience. Melissa works with organisations globally to unlock the value of accurate customer data, including Bank of America, Creditsafe, MetaBank, Tranzfar, BAE Systems, GSK, car2go, Microsoft, the NHS, and the For